Opus Genetics (IRD) Other Non-Current Assets (2010 - 2020)
Opus Genetics' (IRD) quarterly Other Non-Current Assets came in at $25681.0 in Q3 2020, little changed year-on-year from $25681.0 in Q4 2019, and little changed on a QoQ basis from $25681.0 in Q2 2020.
Opus Genetics (IRD) Other Non-Current Assets (2010 - 2020) Analysis & Trends
Opus Genetics (IRD) has 11 years of Other Non-Current Assets data on file, last reported at $25681.0 in Q3 2020.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $25681.0 in Q3 2020; TTM through Sep 2020 was $25681.0, a 0.0% change from a year earlier, with the FY2019 full-year figure at $25681.0, down 16.58% from the prior year.
- Other Non-Current Assets for Q3 2020 stood at $25681.0, roughly flat from $25681.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for IRD reached as high as $30785.0 in Q1 2016 and fell as low as $25681.0 in Q2 2019.
- Historically, Other Non-Current Assets has averaged $29173.2 across 5 years, with a median of $30785.0 in 2016.
- Across the five-year window, Other Non-Current Assets increased 19.87% in 2016 and decreased 16.58% in 2019, its largest moves.
- Year by year, Other Non-Current Assets stood at $30785.0 in 2016, then changed by 0.0% to $30785.0 in 2017, then changed by 0.0% to $30785.0 in 2018, then slipped by 16.58% to $25681.0 in 2019, then changed by 0.0% to $25681.0 in 2020.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $25681.0 in Q3 2020, $25681.0 in Q2 2020, and $25681.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 25,681.00 |
| Jun 30, 2020 | 25,681.00 |
| Mar 31, 2020 | 25,681.00 |
| Dec 31, 2019 | 25,681.00 |
| Sep 30, 2019 | 25,681.00 |
| Jun 30, 2019 | 25,681.00 |
| Mar 31, 2019 | 30,785.00 |
| Dec 31, 2018 | 30,785.00 |
| Sep 30, 2018 | 30,785.00 |
| Jun 30, 2018 | 30,785.00 |
| Mar 31, 2018 | 30,785.00 |
| Dec 31, 2017 | 30,785.00 |
| Sep 30, 2017 | 30,785.00 |
| Jun 30, 2017 | 30,785.00 |
| Mar 31, 2017 | 30,785.00 |
| Dec 31, 2016 | 30,785.00 |
| Sep 30, 2016 | 30,785.00 |
| Jun 30, 2016 | 30,785.00 |
| Mar 31, 2016 | 30,785.00 |
| Dec 31, 2015 | 30,785.00 |